| 000 | 01800 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515031913.0 | ||
| 264 | 0 | _c20070807 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1671-4083 | ||
| 024 | 7 |
_a10.1111/j.1745-7254.2006.00382.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuo, Da-li | |
| 245 | 0 | 0 |
_aRole of inositol 1,4,5-trisphosphate receptors in alpha1-adrenergic receptor-induced cardiomyocyte hypertrophy. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cJul 2006 |
||
| 300 |
_a895-900 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Agonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xbiosynthesis |
| 650 | 0 | 4 |
_aBoron Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aHeart Ventricles |
| 650 | 0 | 4 |
_aHypertrophy _xchemically induced |
| 650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate Receptors _xphysiology |
| 650 | 0 | 4 |
_aLeucine _xmetabolism |
| 650 | 0 | 4 |
_aMacrocyclic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xpathology |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aGao, Jian | |
| 700 | 1 | _aLan, Xiao-mei | |
| 700 | 1 | _aWang, Gang | |
| 700 | 1 | _aWei, Sheng | |
| 700 | 1 | _aXiao, Rui-ping | |
| 700 | 1 | _aHan, Qi-de | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 27 _gno. 7 _gp. 895-900 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1745-7254.2006.00382.x _zAvailable from publisher's website |
| 999 |
_c16381609 _d16381609 |
||